HAT
A histone acetyltransferase (HAT) can be defined as an enzyme that acetylates core histones, which results in important regulatory effects on chromatin structure and assembly, and gene transcription. HATs are evolutionarily conserved from yeast to humans, that HATs generally contain multiple subunits, and that the functions of the catalytic subunit depend largely on the context of the other subunits in those complexes. Histone acetylation is a dynamic reversible process. The balance of histone acetylation is important for proper cellular function and the cell has evolved enzymes that catalyse the removal of acetyl groups, termed histone deacetylases (HDACs). Histone acetyltransferases are a diverse set of enzymes that can be grouped on the basis of their catalytic domains. Some subunits have domains that cooperate to recruit the HAT to the appropriate location in the genome; these include bromodomains, chromodomains, WD40 repeats, Tudor domains and PHD fingers.
References
1.Lee KK and Workman JL. Nat Rev Mol Cell Biol. 2007;8(4):284–295.
References
1.Lee KK and Workman JL. Nat Rev Mol Cell Biol. 2007;8(4):284–295.
Chromatin/Epigenetic
HAT
-
CPTH6 hydrobromide
catalog no : M17047
cas no: ——
CPTH6 hydrobromide is a thiazole derivative that can reduce histone acetylation and histone acetyltransferase (HAT) activity in human leukemia cells. -
Garcinol
catalog no : M15966
cas no: 78824-30-3
Garcinol (Camboginol) is a potent, natural inhibitor of histone acetyltransferases (HATs) p300 (IC50=7 uM) and PCAF (IC50=5 uM) both in vitro and in vivo. -
TTK21
catalog no : M15723
cas no: 709676-56-2
TTK21 (CBP-p300 activator TTK21) is a small molecule activator of CBP/p300 histone acetyltransferase activity with a maximal effect at a concentration of 275 uM. -
CTPB
catalog no : M15161
cas no: 586976-24-1
CTPB is an anacardic acid derivative, was reported as a selective activator of p300 (KAT3B) HAT activity but not PCAF (KAT2B). -
CPTH2
catalog no : M14229
cas no: 357649-93-5
CPTH2 is a specific histone acetyltransferase inhibitor modulating Gcn5 network in vitro and in vivo.